SQA Regulatory Surveillance Summary 3 | Monthly Update 2021
SQA
APRIL 30, 2021
726/2004, 09 March 2021. 726/2004 , which essentially means duplicate MAAs for products authorized via the centralized procedure. EC Issues Notice on the Handling of Duplicate Marketing Authorization Applications (MAAs) of Pharmaceutical Products under Article 82(1) of Regulation (EC) No. Under Article 82(1) of Regulation (EC) No.
Let's personalize your content